Why the study?
Does restarting oral anticoagulant treatment reduce ischemic stroke, systemic embolism, and mortality in patients with atrial fibrillation who survive an intracranial hemorrhage?
Population
1,752 patients with atrial fibrillation who survived an incident intracranial hemorrhage while on oral…
Comparison
Restarting oral anticoagulant treatment after… vs No treatment or antiplatelet therapy
Design
Cohort
Follow-up
1 year
Authors
Loading...
May support resuming OAC after ICH in AF; leaves open need for RCTs to confirm net benefit.
Does restarting oral anticoagulant treatment reduce ischemic stroke, systemic embolism, and mortality in patients with atrial fibrillation who survive an intracranial hemorrhage?
Restarting oral anticoagulation after an intracranial hemorrhage in patients with atrial fibrillation is associated with a significantly lower risk of ischemic stroke and all-cause mortality compared to no treatment.
Nielsen et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: